Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Dll4-Notch signaling in regulation of tumor angiogenesis.

Liu Z, Fan F, Wang A, Zheng S, Lu Y.

J Cancer Res Clin Oncol. 2014 Apr;140(4):525-36. doi: 10.1007/s00432-013-1534-x. Epub 2013 Oct 10. Review.

PMID:
24114288
2.

New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.

Oon CE, Harris AL.

Biochem Soc Trans. 2011 Dec;39(6):1612-8. doi: 10.1042/BST20110721. Review.

PMID:
22103496
3.

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.

Li JL, Sainson RC, Oon CE, Turley H, Leek R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, Wu H, Chowdhury PS, Russell AJ, Montgomery CP, Poulsom R, Harris AL.

Cancer Res. 2011 Sep 15;71(18):6073-83. doi: 10.1158/0008-5472.CAN-11-1704. Epub 2011 Jul 29.

4.

Delta-like 4/Notch signaling promotes Apc Min/+ tumor initiation through angiogenic and non-angiogenic related mechanisms.

Badenes M, Trindade A, Pissarra H, Lopes-da-Costa L, Duarte A.

BMC Cancer. 2017 Jan 13;17(1):50. doi: 10.1186/s12885-016-3036-0. Erratum in: BMC Cancer. 2017 Mar 21;17 (1):205.

5.

The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.

Zhang JF, Chen Y, Qiu XX, Tang WL, Zhang JD, Huang JH, Lin GS, Wang XF, Lin ZX.

Tumour Biol. 2016 Mar;37(3):3797-805. doi: 10.1007/s13277-015-4202-8. Epub 2015 Oct 15.

PMID:
26472724
6.

Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.

Li JL, Harris AL.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3094-110. Review.

PMID:
19273260
7.

Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.

Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA, Harris AL.

Cancer Res. 2007 Dec 1;67(23):11244-53.

8.

Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells.

Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL.

J Biol Chem. 2014 Aug 15;289(33):23168-76. doi: 10.1074/jbc.M114.576512. Epub 2014 Jun 17.

9.

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.

Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A.

BMC Cancer. 2010 Nov 23;10:641. doi: 10.1186/1471-2407-10-641.

10.

Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.

Yu S, Sun J, Zhang J, Xu X, Li H, Shan B, Tian T, Wang H, Ma D, Ji C.

Histol Histopathol. 2013 Feb;28(2):277-84. doi: 10.14670/HH-28.277.

PMID:
23275310
11.

Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.

You C, Sandalcioglu IE, Dammann P, Felbor U, Sure U, Zhu Y.

J Cell Mol Med. 2013 Mar;17(3):407-18. doi: 10.1111/jcmm.12022. Epub 2013 Feb 7.

12.

Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4/Notch1.

Pedrosa AR, Trindade A, Fernandes AC, Carvalho C, Gigante J, Tavares AT, DiƩguez-Hurtado R, Yagita H, Adams RH, Duarte A.

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1134-46. doi: 10.1161/ATVBAHA.114.304741. Epub 2015 Mar 12.

13.

Delta-like 4/Notch signaling and its therapeutic implications.

Yan M, Plowman GD.

Clin Cancer Res. 2007 Dec 15;13(24):7243-6. Review.

14.

Notch signaling regulates tumor angiogenesis by diverse mechanisms.

Dufraine J, Funahashi Y, Kitajewski J.

Oncogene. 2008 Sep 1;27(38):5132-7. doi: 10.1038/onc.2008.227. Review.

15.
16.

VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis.

Thurston G, Kitajewski J.

Br J Cancer. 2008 Oct 21;99(8):1204-9. doi: 10.1038/sj.bjc.6604484. Epub 2008 Sep 30. Review.

17.

Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.

Liu YR, Guan YY, Luan X, Lu Q, Wang C, Liu HJ, Gao YG, Yang SC, Dong X, Chen HZ, Fang C.

Biomaterials. 2015 Feb;42:161-71. doi: 10.1016/j.biomaterials.2014.11.039. Epub 2014 Dec 16.

PMID:
25542804
18.

Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells.

Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li JL, Harris AL.

Microvasc Res. 2008 Mar;75(2):144-54. Epub 2007 Jun 29.

PMID:
17692341
19.

Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4).

Jovanovic VP, Sauer CM, Shawber CJ, Gomez R, Wang X, Sauer MV, Kitajewski J, Zimmermann RC.

Reprod Biol Endocrinol. 2013 May 15;11:43. doi: 10.1186/1477-7827-11-43.

20.

Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.

Benedito R, Rocha SF, Woeste M, Zamykal M, Radtke F, Casanovas O, Duarte A, Pytowski B, Adams RH.

Nature. 2012 Mar 18;484(7392):110-4. doi: 10.1038/nature10908.

PMID:
22426001

Supplemental Content

Support Center